Loss of MTSS1 Expression is an Independent Prognostic Factor for Hilar Cholangiocarcinoma

By Wang Fei   Liu Yulong   Zhang Hao  

Pathology & Oncology Research, Vol. 19, Iss. 4, 2013-10 ,pp. : 815-820

Springer Publishing Company

Access to resources Recommend Favorite

Expression Level of Hepatoma-Derived Growth Factor Correlates with Tumor Recurrence of Esophageal Carcinoma

By Yamamoto Shinji   Tomita Yasuhiko   Hoshida Yoshihiko   Morii Eiichi   Yasuda Takushi   Doki Yuichiro   Aozasa Katsuyuki   Uyama Hirokazu   Nakamura Hideji   Monden Morito  

Annals of Surgical Oncology, Vol. 14, Iss. 7, 2007-07 ,pp. : 2141-2149

Springer Publishing Company

Access to resources Recommend Favorite

Downregulation of hepatoma-derived growth factor suppresses the malignant phenotype of U87 human glioma cells

By          

Oncology Reports, Vol. 28, Iss. 1, 2012-01 ,pp. : 62-68

Spandidos Publications

Access to resources Recommend Favorite

Apoptosis of human colorectal carcinoma cells is induced by blocking hepatoma-derived growth factor

By Liao Fei  

Medical Oncology, Vol. 27, Iss. 4, 2010-12 ,pp. : 1219-1226

Humana Press, Inc

Access to resources Recommend Favorite

Platelet-derived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma

By Boonjaraspinyo Sirintip  

Tumor Biology, Vol. 33, Iss. 5, 2012-10 ,pp. : 1785-1802

Springer Publishing Company

Access to resources Recommend Favorite